SCHEMBL8569721

SCHEMBL8569721

Cc1ccnc(CCCCCO)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UHRF1 Q96T88 1/20 0.41
CCR1 P32246 1/20 0.41
CCR5 P51681 1/20 0.41
CCR8 P51685 1/20 0.41
KDM4E B2RXH2 3/20 0.40
HTR1A P08908 4/20 0.40
ADRA1D P25100 4/20 0.40
ADRA1A P35348 4/20 0.40
ADRA1B P35368 4/20 0.40
NOS1 P29475 3/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
NOS3 P29474 1/20 0.38
NOS2 P35228 1/20 0.38
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
PLAU P00749 1/20 0.36
HRH1 P35367 1/20 0.36
KDM1A O60341 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20099912 0.98 UHRF1 (0.42) UHRF1CCR1CCR5CCR8KDM4E
SCHEMBL8565055 0.93 UHRF1 (0.43) UHRF1CCR1CCR5CCR8KDM4E
Bromide SCHEMBL38664578 0.89 UHRF1 (0.41) UHRF1CCR1CCR5CCR8KDM4E
Hydrochloric Acid SCHEMBL10858865 0.87 UHRF1 (0.48) UHRF1CCR1CCR5CCR8KDM4E
SCHEMBL6466772 0.85 UHRF1 (0.46) UHRF1CCR1CCR5CCR8KDM4E
SCHEMBL2547957 0.84 KCNH2 (0.48) UHRF1CCR1CCR5CCR8KDM4E
SCHEMBL28878273 0.84 KCNH2 (0.48) UHRF1CCR1CCR5CCR8KDM4E
SCHEMBL28183218 0.84 KCNH2 (0.48) UHRF1CCR1CCR5CCR8KDM4E
SCHEMBL8569698 0.84 UHRF1 (0.42) UHRF1CCR1CCR5CCR8KDM4E
SCHEMBL2551597 0.84 KCNH2 (0.48) UHRF1CCR1CCR5CCR8KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3315492-B1 PYRAZOLE DERIVATIVE, OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF KISSEI PHARMACEUTICAL (JP) 2020-09-16 EP disclosed
EP-0824524-A1 ALPHA-SUBSTITUTED PYRIMIDINE-THIOALKYL AND ALKYLETHER COMPOUNDS AS INHIBITORS OF VIRAL REVERSE TRANSCRIPTASE PHARMACIA & UPJOHN COMPANY (US) 1998-02-25 EP disclosed